Back to All Events

Clinical development of therapeutic platforms for monogenic diseases and implications for NBS

PJ Brooks

NIH

Previous
Previous
October 10

Societal Implications of gNBS

Next
Next
October 10

Broadening Diversity in Genomics: The BabySeq Experience